Zobrazeno 1 - 2
of 2
pro vyhledávání: '"feniltiohidantoína"'
Autor:
Vincenza Conteduca, Jayaram, A., Romero-Laorden, N., Wetterskog, D., Salvi, S., Gurioli, G., Scarpi, E., Castro, E., Marin-Aguilera, M., Lolli, C., Schepisi, G., Maugeri, A., Wingate, A., Farolfi, A., Casadio, V., Medina, A., Puente, J., Vidal, Mjm, Morales-Barrera, R., Villa-Guzmán, Jc, Hernando, S., Rodriguez-Vida, A., González-Del-Alba, A., Mellado, B., Gonzalez-Billalabeitia, E., Olmos, D., Attard, G., Giorgi, U.
Publikováno v:
European Urology
Repositorio Institucional de la Consejería de Sanidad de la Comunidad de Madrid
Consejería de Sanidad de la Comunidad de Madrid
Università degli studi di Foggia-IRIS
Repositorio Institucional de la Consejería de Sanidad de la Comunidad de Madrid
Consejería de Sanidad de la Comunidad de Madrid
Università degli studi di Foggia-IRIS
Plasma androgen receptor (AR) gain identifies metastatic castration-resistant prostate cancer (mCRPC) patients with worse outcome on abiraterone/enzalutamide, but its relevance in the context of taxane chemotherapy is unknown. We aimed to evaluate wh
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::5a3b2d792bd066c01c1b2f901c9f01ab
http://europepmc.org/articles/PMC6377278
http://europepmc.org/articles/PMC6377278
Autor:
Conteduca, Vincenza, Wetterskog, Daniel, Sharabiani, Grande, Enrique, Fernandez Perez, M. P., Jayaram, Anuradha, Salvi, S., Castellano, Daniel, Romanel, A., Lolli, C., Casadio, Valentina, Gurioli, G., Amadori, D., Font, A., Vazquez Estevez, S., González del Alba, A., Mellado, B., Fernandez Calvo, O., Méndez Vidal, M. J., Climent, M. A., Durán, I, Gallardo, E., Rodríguez Sánchez, Ángel, Santander, C., Sáez, M. I., Puente, J., Gasi Tandefelt, D., Wingate, Anna, Dearnaley, D., Demichelis, F., De Giorgi, Ugo, Gonzalez Billalabeitia, E., Attard, Gerhardt, Spanish Oncology Genitourinary Group, Universitat Autònoma de Barcelona
Publikováno v:
Dipòsit Digital de Documents de la UAB
Universitat Autònoma de Barcelona
Universitat Autònoma de Barcelona
Background: There is an urgent need to identify biomarkers to guide personalized therapy in castration-resistant prostate cancer (CRPC). We aimed to clinically qualify androgen receptor (AR) gene status measurement in plasma DNA using multiplex dropl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::3f7a13e508cd658a892e3a732492dab6
https://hdl.handle.net/20.500.13003/9759
https://hdl.handle.net/20.500.13003/9759
